Company Profiles

driven by the PitchBook Platform

Deltanoid Pharmaceuticals

Deltanoid Pharmaceuticals
1999 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
$12M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of bio-pharmaceutical drugs designed to improve human health. The company's bio-pharmaceutical drugs are used for the treatment of human diseases in a variety of areas including renal disease, osteoporosis, vitamin D deficiency and acne, enabling doctors to transform health outcomes for patients with diseases of the kidney, bone and skin.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
1603 Monroe Street
Madison, WI 53711
United States

+1 (608) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Deltanoid Pharmaceuticals’s full profile, request a free trial.

Deltanoid Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 15-Jan-2008 $12M 000.00 000.00 Completed Startup
1. Early Stage VC (Series A) 04-Jun-2001 00.000 00.000 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Deltanoid Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Deltanoid Pharmaceuticals Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Individual Investor Angel (individual) Minority 000 0000 000000 0
Keane D'Souza Venture Capital Venture Capital Minority 000 0000 000000 0
Mason Wells PE/Buyout Minority 000 0000 000000 0
Ragazzi Other Minority 000 0000 000000 0
SAFC Other Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Deltanoid Pharmaceuticals Executive Team (6)

Name Title Board
Seat
Contact
Info
Hector DeLuca Ph.D Co-Founder, President, Board Member & Co-Chief Executive Officer
Loreen Mershimer Co-Chief Executive Officer & Board Member
Lori Plum Ph.D Chief Scientific Officer & Board Member
Linda Leikness Chief Business Officer, Secretary and Treasurer
Margaret Clagett-Dame Executive Vice President, Co-Founder and Board Member

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Deltanoid Pharmaceuticals Board Members (7)

Name Representing Role Since Contact
Info
Carl Gulbrandsen Ph.D WARF Board Member 000 0000
John Neis Venture Investors Board Member 000 0000
Loreen Mershimer Deltanoid Pharmaceuticals Co-Chief Executive Officer & Board Member 000 0000
Lori Plum Ph.D Deltanoid Pharmaceuticals Chief Scientific Officer & Board Member 000 0000

3 Former Board Members

You’re viewing 4 of 7 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com